Psychedelic Therapy EO Is a Major Step for Mental Health, but Access Barriers Remain, Experts Say

For decades, psychedelic medicine has occupied a complex and often contentious space between restrictive federal scheduling and emerging clinical research. However, a recent executive order (EO) signed by President Donald J. Trump has initiated a formal effort to accelerate the research, regulation, and integration of these substances into the national health care landscape.¹ The policy directs federal agencies to streamline pathways for breakthrough mental health treatments, specifically targeting the needs of the veteran community and addressing the ongoing national mental health crisis.